CN105477227A - Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine - Google Patents

Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine Download PDF

Info

Publication number
CN105477227A
CN105477227A CN201510943413.8A CN201510943413A CN105477227A CN 105477227 A CN105477227 A CN 105477227A CN 201510943413 A CN201510943413 A CN 201510943413A CN 105477227 A CN105477227 A CN 105477227A
Authority
CN
China
Prior art keywords
parts
medicine
rhizoma
facial paralysis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510943413.8A
Other languages
Chinese (zh)
Inventor
刘培英
赵永东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510943413.8A priority Critical patent/CN105477227A/en
Publication of CN105477227A publication Critical patent/CN105477227A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884Arisaema, e.g. Jack in the pulpit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237Notopterygium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486Millettia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732Chaenomeles, e.g. flowering quince
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating peripheral facial paralysis for the department of neurology and a preparation method of the medicine. The medicine is prepared from the following raw materials in parts by weight: 12-20 parts of rhizoma arisaematis, 15-25 parts of ramulus mori, 20-28 parts of pawpaw, 6-13 parts of herba asari, 7-13 parts of folium artemisiae argyi, 1-5 parts of notopterygium root, 4-10 parts of divaricate saposhnikovia root, 12-24 parts of cortex acanthopanacis, 10-20 parts of caulis spatholobi, 5-15 parts of rhizoma ligustici wallichii, and 25-30 parts of radix astragali. According to the medicine, the raw materials are in reasonable composition, so that the medicine can promote the smooth blood circulation, improve the tissue metabolism, and relieve the inflammation and edema, has good curative effects for peripheral facial paralysis, is short in course of treatment, high in cure rate, and free of any side effect, no relapse of peripheral facial paralysis occurs, the preparation method is simple, the medicine is convenient to take, and the preparation method is easy to implement and popularize.

Description

A kind of Neurology Department medicine being used for the treatment of peripheral facial paralysis and preparation method thereof
Technical field
The present invention relates to field of medicaments, be specifically related to a kind of Neurology Department medicine being used for the treatment of peripheral facial paralysis and preparation method thereof.
Background technology
Peripheral facial paralysis refers to idiopathic facial palsy, and the current cause of disease is not bright.Modern medicine thinks that pathogeny may be relevant with viral infection, cold stimulation, autonomic nerve instability etc.Peripheral facial paralysis system commonly encountered diseases, any age all can fall ill, usual Acute onset, within a few hours or 1 ~ 2 day, reach peak, and sick just can have pain after angle of mandible or ear.Cardinal symptom is disease side surface part histrionic muscles flaccid paralysis, palpebral fissure expands, volume stricture of vagina disappears, paranasal ala sulcus is smooth, ptosis of labial angle, face are led to strong side, can not lift the actions such as eyebrow, wrinkle volume, eye closing, drum mouth.This several method of operative treatment, physiotherapy and Drug therapy is generally adopted in current clinical treatment.Operative treatment needs to sacrifice other nerve if accessory nerve, phrenic nerves are to reach the gentleness of correlation surface nerve more, a kind of damaging therapy time comparatively speaking, and there is certain risk; The methods such as physiotherapy many employings acupuncture, massage, massage, physical therapy is relatively long for the course for the treatment of, and cure rate is low, and effect is also undesirable; Western medicine effectively cannot treat facial neuritis, and takes Western medicine and have more side effect, costly.The traditional Chinese medical science thinks that this disease is how hollow by meridians, and heresy of wind and cold or wind heat is taken advantage of a weak point in opponent's defence bright, the shaoyang channel network of invasion and attack sun, and cause, muscles along the regular meridians stagnant through vapour lock to lose and support, muscles vertical delaying does not receive and cause.Also have at present the effective prescriptions of Chinese medicine of many clinical use, but there is medication not refine, not rigorous, medicine time is long, the not high situation of curative effect.
Summary of the invention
For the deficiencies in the prior art, the invention provides that a kind of good effect, short treating period, cure rate are high, the medicine for the treatment of peripheral facial paralysis that has no side effect and preparation method thereof.
For realizing above object, the present invention is achieved by the following technical programs:
Neurology Department is used for the treatment of a medicine for peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 12-20 part, Ramulus Mori 15-25 part, Fructus Chaenomelis 20-28 part, Herba Asari 6-13 part, Folium Artemisiae Argyi 7-13 part, Rhizoma Et Radix Notopterygii 1-5 part, Radix Saposhnikoviae 4-10 part, Cortex Acanthopancis 12-24 part, Caulis Spatholobi 10-20 part, Rhizoma Chuanxiong 5-15 part, Radix Astragali 25-30 part.
Preferably, described Neurology Department is used for the treatment of the medicine of peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 14-17 part, Ramulus Mori 18-23 part, Fructus Chaenomelis 22-26 part, Herba Asari 8-11 part, Folium Artemisiae Argyi 9-11 part, Rhizoma Et Radix Notopterygii 2-4 part, Radix Saposhnikoviae 6-9 part, Cortex Acanthopancis 16-21 part, Caulis Spatholobi 13-16 part, Rhizoma Chuanxiong 7-12 part, Radix Astragali 25-30 part.
Preferably, described Neurology Department is used for the treatment of the medicine of peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 15 parts, Ramulus Mori 20 parts, Fructus Chaenomelis 25 parts, Herba Asari 10 parts, Folium Artemisiae Argyi 10 parts, Rhizoma Et Radix Notopterygii 3 parts, Radix Saposhnikoviae 8 parts, Cortex Acanthopancis 18 parts, Caulis Spatholobi 15 parts, Rhizoma Chuanxiong 9 parts, the Radix Astragali 27 parts.
Neurology Department is used for the treatment of the preparation method of the medicine of peripheral facial paralysis, comprises the following steps:
(1) Rhizoma Arisaematis, Ramulus Mori, Fructus Chaenomelis, Herba Asari, Folium Artemisiae Argyi, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Cortex Acanthopancis, Caulis Spatholobi, Rhizoma Chuanxiong, the Radix Astragali are taken according to weight portion, add 8 times of soak by water 2h, filter, obtain one filtering residue with together with decoction liquor;
(2) one filtering residue is added 4 times of water, decoct 30min, filter to obtain two road decoction liquor;
(3) merge twice decoction liquor, big fire is boiled, then slow fire boils 10min, is divided into 3 doses to take.
Beneficial effect of the present invention: Ramulus Mori dispelling wind and removing obstruction in the collateral in the present invention, Fructus Chaenomelis soothing the channels and quicking the network vessels, Herba Asari expelling wind and cold, understand things pain-stopping, Rhizoma Arisaematis drying dampness to eliminate phlegm, expelling wind and relieving convulsion, notopterygium wind dispelling pain relieving, Radix Saposhnikoviae expelling wind to relieve convulsion, Folium Artemisiae Argyi dispelling cold and removing dampness, eliminate the phlegm, Cortex Acanthopancis expelling wind and activating blood circulation, and Cortex Acanthopancis and Folium Artemisiae Argyi have the effect of excitor nerve, Caulis Spatholobi blood circulation promoting and enriching, channels sootheing and network vessel quickening, Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping, the righting of Radix Astragali QI invigorating is dispeled the wind, various former medicine reasonable compatibility, can blood circulation promoting unimpeded, strengthen tissue metabolism, reduce inflammation and edema, to peripheral facial paralysis good effect, and short treating period, cure rate is high, do not recur, without any side effects, preparation method is simple, easy practice and extension.
Detailed description of the invention
For making the object of the embodiment of the present invention, technical scheme and advantage clearly, below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described, obviously, described embodiment is the present invention's part embodiment, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making the every other embodiment obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1:
Neurology Department is used for the treatment of a medicine for peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 12 parts, Ramulus Mori 25 parts, Fructus Chaenomelis 20 parts, Herba Asari 13 parts, Folium Artemisiae Argyi 7 parts, Rhizoma Et Radix Notopterygii 5 parts, Radix Saposhnikoviae 4 parts, Cortex Acanthopancis 24 parts, Caulis Spatholobi 10 parts, Rhizoma Chuanxiong 15 parts, the Radix Astragali 25 parts.
Neurology Department is used for the treatment of the preparation method of the medicine of peripheral facial paralysis, comprises the following steps:
(1) Rhizoma Arisaematis, Ramulus Mori, Fructus Chaenomelis, Herba Asari, Folium Artemisiae Argyi, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Cortex Acanthopancis, Caulis Spatholobi, Rhizoma Chuanxiong, the Radix Astragali are taken according to weight portion, add 8 times of soak by water 2h, filter, obtain one filtering residue with together with decoction liquor;
(2) one filtering residue is added 4 times of water, decoct 30min, filter to obtain two road decoction liquor;
(3) merge twice decoction liquor, big fire is boiled, then slow fire boils 10min, is divided into 3 doses to take.
Case: Mrs Wang, 35 years old, rises when washing one's face and finds that the left corners of the mouth is crooked morning in winter, and left face is numb simultaneously, and left eyebrow praises difficulty, is peripheral facial paralysis after diagnosing.Drink embodiment of the present invention medicine, each 300ml, 3 times on the one, fully recover after 12 days.
Embodiment 2:
Neurology Department is used for the treatment of a medicine for peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 20 parts, Ramulus Mori 15 parts, Fructus Chaenomelis 28 parts, Herba Asari 6 parts, Folium Artemisiae Argyi 13 parts, Rhizoma Et Radix Notopterygii 1 part, Radix Saposhnikoviae 10 parts, Cortex Acanthopancis 12 parts, Caulis Spatholobi 20 parts, Rhizoma Chuanxiong 5 parts, the Radix Astragali 30 parts.
Preparation method is with embodiment 1.
Embodiment 3:
Neurology Department is used for the treatment of a medicine for peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 14 parts, Ramulus Mori 23 parts, Fructus Chaenomelis 22 parts, Herba Asari 11 parts, Folium Artemisiae Argyi 9 parts, Rhizoma Et Radix Notopterygii 4 parts, Radix Saposhnikoviae 6 parts, Cortex Acanthopancis 21 parts, Caulis Spatholobi 13 parts, Rhizoma Chuanxiong 12 parts, the Radix Astragali 25 parts.
Preparation method is with embodiment 1.
Embodiment 4:
Neurology Department is used for the treatment of a medicine for peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 17 parts, Ramulus Mori 18 parts, Fructus Chaenomelis 26 parts, Herba Asari 8 parts, Folium Artemisiae Argyi 11 parts, Rhizoma Et Radix Notopterygii 2 parts, Radix Saposhnikoviae 9 parts, Cortex Acanthopancis 16 parts, Caulis Spatholobi 16 parts, Rhizoma Chuanxiong 7 parts, the Radix Astragali 30 parts.
Preparation method is with embodiment 1.
Case: Mr. Li, 41 years old, right front volume wrinkles on one's forehead disappeared, right corners of the mouth declivity, and the corners of the mouth is not closed completely, and often cause saliva outflow, right cheek is numb, and stingless excitation, speaks and pronounce indistinctly, and is peripheral facial paralysis after diagnosing.Drink embodiment of the present invention medicine, each 300ml, 3 times on the one, after 10 days, most of facial expression muscle recovers better, within 18 days, to be completely recovered, and without recurrence in 2 years.
Embodiment 5:
Neurology Department is used for the treatment of a medicine for peripheral facial paralysis, is made up of the raw material of following weight portion: Rhizoma Arisaematis 15 parts, Ramulus Mori 20 parts, Fructus Chaenomelis 25 parts, Herba Asari 10 parts, Folium Artemisiae Argyi 10 parts, Rhizoma Et Radix Notopterygii 3 parts, Radix Saposhnikoviae 8 parts, Cortex Acanthopancis 18 parts, Caulis Spatholobi 15 parts, Rhizoma Chuanxiong 9 parts, the Radix Astragali 27 parts.
Preparation method is with embodiment 1.
Case: Mr. Zhang, 68 years old, right disapperance of nasolabial sulcus, right eye was closed not tight, and right eyebrow praises obstacle, and tongue is crooked to the right, and cheek drops, and the gas leakage of the drum cheek, pain after auris dextra is peripheral facial paralysis after diagnosing.Drink embodiment of the present invention medicine, each 300ml, 3 times on the one, after 10 days, most of facial expression muscle and partial act recover better, within 23 days, to be completely recovered, and without recurrence in 2 years.
To sum up, the embodiment of the present invention has following beneficial effect: various former medicine reasonable compatibility, can blood circulation promoting unimpeded, strengthen tissue metabolism, reduce inflammation and edema, to peripheral facial paralysis good effect, and short treating period, cure rate is high, do not recur, without any side effects, preparation method is simple, taking convenience, easy practice and extension.
It should be noted that, in this article, the such as relational terms of first and second grades and so on is only used for an entity or operation to separate with another entity or operating space, and not necessarily requires or imply the relation that there is any this reality between these entities or operation or sequentially.And, term " comprises ", " comprising " or its any other variant are intended to contain comprising of nonexcludability, thus make to comprise the process of a series of key element, method, article or equipment and not only comprise those key elements, but also comprise other key elements clearly do not listed, or also comprise by the intrinsic key element of this process, method, article or equipment.When not more restrictions, the key element limited by statement " comprising ... ", and be not precluded within process, method, article or the equipment comprising described key element and also there is other identical element.
Above embodiment only in order to technical scheme of the present invention to be described, is not intended to limit; Although with reference to previous embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that: it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature; And these amendments or replacement, do not make the essence of appropriate technical solution depart from the spirit and scope of various embodiments of the present invention technical scheme.

Claims (4)

1. a Neurology Department is used for the treatment of the medicine of peripheral facial paralysis, it is characterized in that, be made up of the raw material of following weight portion: Rhizoma Arisaematis 12-20 part, Ramulus Mori 15-25 part, Fructus Chaenomelis 20-28 part, Herba Asari 6-13 part, Folium Artemisiae Argyi 7-13 part, Rhizoma Et Radix Notopterygii 1-5 part, Radix Saposhnikoviae 4-10 part, Cortex Acanthopancis 12-24 part, Caulis Spatholobi 10-20 part, Rhizoma Chuanxiong 5-15 part, Radix Astragali 25-30 part.
2. Neurology Department as claimed in claim 1 is used for the treatment of the medicine of peripheral facial paralysis, it is characterized in that, be made up of the raw material of following weight portion: Rhizoma Arisaematis 14-17 part, Ramulus Mori 18-23 part, Fructus Chaenomelis 22-26 part, Herba Asari 8-11 part, Folium Artemisiae Argyi 9-11 part, Rhizoma Et Radix Notopterygii 2-4 part, Radix Saposhnikoviae 6-9 part, Cortex Acanthopancis 16-21 part, Caulis Spatholobi 13-16 part, Rhizoma Chuanxiong 7-12 part, Radix Astragali 25-30 part.
3. Neurology Department as claimed in claim 1 is used for the treatment of the medicine of peripheral facial paralysis, it is characterized in that, be made up of the raw material of following weight portion: Rhizoma Arisaematis 15 parts, Ramulus Mori 20 parts, Fructus Chaenomelis 25 parts, Herba Asari 10 parts, Folium Artemisiae Argyi 10 parts, Rhizoma Et Radix Notopterygii 3 parts, Radix Saposhnikoviae 8 parts, Cortex Acanthopancis 18 parts, Caulis Spatholobi 15 parts, Rhizoma Chuanxiong 9 parts, the Radix Astragali 27 parts.
4. the Neurology Department as described in as arbitrary in claim 1-3 is used for the treatment of a preparation method for the medicine of peripheral facial paralysis, it is characterized in that, comprises the following steps:
(1) Rhizoma Arisaematis, Ramulus Mori, Fructus Chaenomelis, Herba Asari, Folium Artemisiae Argyi, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Cortex Acanthopancis, Caulis Spatholobi, Rhizoma Chuanxiong, the Radix Astragali are taken according to weight portion, add 8 times of soak by water 2h, filter, obtain one filtering residue with together with decoction liquor;
(2) one filtering residue is added 4 times of water, decoct 30min, filter to obtain two road decoction liquor;
(3) merge twice decoction liquor, big fire is boiled, then slow fire boils 10min, is divided into 3 doses to take.
CN201510943413.8A 2015-12-16 2015-12-16 Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine Pending CN105477227A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510943413.8A CN105477227A (en) 2015-12-16 2015-12-16 Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510943413.8A CN105477227A (en) 2015-12-16 2015-12-16 Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine

Publications (1)

Publication Number Publication Date
CN105477227A true CN105477227A (en) 2016-04-13

Family

ID=55664741

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510943413.8A Pending CN105477227A (en) 2015-12-16 2015-12-16 Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine

Country Status (1)

Country Link
CN (1) CN105477227A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106177721A (en) * 2016-09-26 2016-12-07 刘伟 A kind of medicine treating Neurology Department peripheral neuromuscular disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101259257A (en) * 2008-04-16 2008-09-10 逯传玲 Preparation of Chinese medicine for treating facial neuritis
CN103933344A (en) * 2014-04-11 2014-07-23 胡海波 Drug preparation for treating facial neuritis
CN104435472A (en) * 2013-09-13 2015-03-25 孙建民 Recovery prescription for treating hemiplegia

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101259257A (en) * 2008-04-16 2008-09-10 逯传玲 Preparation of Chinese medicine for treating facial neuritis
CN104435472A (en) * 2013-09-13 2015-03-25 孙建民 Recovery prescription for treating hemiplegia
CN103933344A (en) * 2014-04-11 2014-07-23 胡海波 Drug preparation for treating facial neuritis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106177721A (en) * 2016-09-26 2016-12-07 刘伟 A kind of medicine treating Neurology Department peripheral neuromuscular disease

Similar Documents

Publication Publication Date Title
CN104013702B (en) One treats hypertensive fumigation and wash method foot bath Chinese medicine
CN105477227A (en) Medicine for treating peripheral facial paralysis for department of neurology and preparation method of medicine
CN103251755A (en) Chinese medicinal preparation for treating facial neuritis
CN103520289B (en) A kind of Chinese medicine composition for the treatment of constipation and its preparation method and application
CN101461873B (en) Chinese patent medicine for treating facial paralysis and preparation method thereof
CN104706852A (en) External traditional Chinese medicine composition capable of improving eyesight, preparation method and applications thereof
CN103948684A (en) Externally-applied liniment for treating leucoderma
CN104083445B (en) One treats leukodermic external application Chinese medicine
CN104415252A (en) Traditional Chinese medicine water decoction for treating ichthyosis
CN103877214B (en) The herb liquid of a kind of whitening and speckle dispelling, eliminating toxin and beautifying the skin
Liu Therapeutic efficacy observation on combining auricular and routine acupuncture for peripheral facial paralysis in acute stage
CN103417857B (en) Traditional Chinese medicine composition for treating hypertension
CN107714768A (en) A kind of Chinese medicine composition for treating interior external opculopathy disease and its preparation method and application
CN105853833A (en) Traditional Chinese medicine wine for treating tinnitus and preparation method thereof
Feng et al. Clinical observation on acupoint sticking therapy plus electroacupuncture for treating peripheral facial paralysis
CN106110074A (en) One treats neurasthenic Chinese medicine
CN104758646A (en) Traditional Chinese medicine composition for treating glaucoma and preparation method thereof
CN104225525A (en) Traditional Chinese medicinal composition for treating hair loss as well as preparation method and application thereof
CN105327052A (en) Drug for treating facial paralysis
CN104013940A (en) Traditional Chinese medicine for fumigation foot bath to treat insomnia
CN105434821A (en) Traditional Chinese medicine preparation for treating prosopalgia
CN105031165A (en) Traditional Chinese medicine for treating nerve headache and preparation method thereof
CN105079387A (en) Traditional Chinese medicine for treating prosopoplegia
CN104491403A (en) Medicine for treating central retinochoroiditis and preparation method
CN104383399A (en) Wine for treating traumatic injury

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160413

RJ01 Rejection of invention patent application after publication